Publications by authors named "S Jelinski"
Objective: To evaluate health system use, health outcomes, and avoided costs when patients with chronic gastrointestinal (GI) conditions are managed in the medical home.
Design: A retrospective, observational cohort study was conducted through a single-point-of-entry referral system.
Setting: Calgary, Alta.
Article Synopsis
- The study aimed to create and test a report card for endoscopic retrograde cholangiopancreatography (ERCP) to improve audit and feedback, which is less researched compared to tools for procedures like colonoscopy.
- The report card incorporated various indicators for assessing technical performance, adverse events, and patient experiences, with positive feedback from ERCP specialists on its content but concerns over the practicality of gathering detailed data for evaluation.
- Despite challenges in data acquisition, the developed report card shows promise as a useful audit tool, especially with future advancements in video recording and AI technology aiding its implementation in clinical settings.
Study Objective: Pregnant women often seek care in an emergency department (ED). We sought to describe the frequency, characteristics, and factors associated with increased ED visits during pregnancy.
Methods: We conducted a retrospective cohort study using administrative health data of all pregnancies resulting in a live birth at 20 or more weeks of gestation in Alberta, Canada, from 2011 to 2017.
Study Objective: Challenges in transitioning from obstetric to primary care in the postpartum period may increase emergency department (ED) visits. This study described the frequency, characteristics, and predictors of maternal ED visits in the postpartum period.
Methods: Retrospective cohort study of all live-birth pregnancies occurring in Alberta (Canada) between 2011 and 2017.
Enzyme and chaperone therapies are used to treat Fabry disease. Such treatments are expensive and require intrusive biweekly infusions; they are also not particularly efficacious. In this pilot, single-arm study (NCT02800070), five adult males with Type 1 (classical) phenotype Fabry disease were infused with autologous lentivirus-transduced, CD34-selected, hematopoietic stem/progenitor cells engineered to express alpha-galactosidase A (α-gal A).
View Article and Find Full Text PDF